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Abstract Dysregulation of the hypothalamic–pituitary–
adrenal (HPA) axis in adults with major depressive disor-
der is among the most consistent and robust biological
ﬁndings in psychiatry. Given the importance of the ado-
lescent transition to the development and recurrence of
depressive phenomena over the lifespan, it is important to
have an integrative perspective on research investigating
the various components of HPA axis functioning among
depressed young people. The present narrative review
synthesizes evidence from the following ﬁve categories of
studies conducted with children and adolescents: (1) those
examining the HPA system’s response to the dexametha-
sone suppression test (DST); (2) those assessing basal HPA
axis functioning; (3) those administering corticotropin-
releasing hormone (CRH) challenge; (4) those incorporat-
ing psychological probes of the HPA axis; and (5) those
examining HPA axis functioning in children of depressed
mothers. Evidence is generally consistent with models of
developmental psychopathology that hypothesize that
atypical HPA axis functioning precedes the emergence of
clinical levels of depression and that the HPA axis becomes
increasingly dysregulated from child to adult manifesta-
tions of depression. Multidisciplinary approaches and lon-
gitudinal research designs that extend across development
are needed to more clearly and usefully elucidate the role
of the HPA axis in depression.
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Pediatric depression is being increasingly recognized as a
major mental health issue. Although it has a complex and
multifaceted etiology, evidence is accumulating that dis-
ruptions to key neurobiological systems characterize at
least some children and youth with depression. This nar-
rative review aims to provide a summary and analysis of
the current state of research investigating the functioning of
the hypothalamic–pituitary–adrenal (HPA) axis among
depressed children and adolescents. By applying a devel-
opmental psychopathology perspective, we seek to identify
the empirical consistencies across multiple lines of
research and, as importantly, to highlight the gaps in the
existing literature in order to identify some key aspects
needed in future research agendas.
The Problem of Child and Adolescent Depression
Depression is among the most prevalent of psychological
disorders. It has been referred to as the ‘‘common cold’’ of
psychopathology (Gotlib and Hammen 2002), a designa-
tion that belies its seriousness. After taking into account the
natural course, mental suffering, and medical morbidity
associated with major depression, the World Health
Organization declared it the leading cause of disability and
the fourth leading cause of premature death worldwide
(Murray and Lopez 1996). One of the primary reasons that
depression stands out as a major public health problem,
with singular costs to individuals and to society, is that this
disorder is often chronic, recurrent, and increasingly
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depression strikes during adolescence the condition is far
more likely to be associated with a persistent, pernicious
course over the lifespan (e.g., Lewinsohn et al. 1999). For
example, as many as 84% of depressed youths will relapse
(Harrington et al. 1996) and these individuals are at par-
ticularly high risk for developing a wide range of psychi-
atric and physical health problems in later adulthood (e.g.,
Achenbach et al. 1995a, b; Fleming et al. 1993; Kandel and
Davies 1986; Puig-Antich et al. 1993; Rao et al. 1995).
Given that childhood and adolescence together constitute a
watershed period of simultaneous, reciprocally inﬂuenced
biological, psychological, cognitive, social, and emotional
development, it is unsurprising that pervasive disruptions
related to juvenile depression have myriad implications and
long-term consequences.
Compounding its impact, the prevalence of depression
in young people increases over development, particularly
during adolescence. Whereas approximately 2% of
13-year-olds experience depression, this rate rises over
eightfold to 17% among 18-year-olds and then remains at
high levels throughout much of adulthood (Abela and
Hankin 2008; Angold et al. 2002; Hankin et al. 1998;
Lewinsohn et al. 1994; Wade et al. 2002). Data from recent
birth cohorts indicate that adolescence has become one of
the most common periods for the onset of ﬁrst depression
(e.g., Andrade et al. 2003; Kessler et al. 2003; Lewinsohn
et al. 1999).
The Importance of a Developmental Perspective
These facts underscore the vital importance of conducting
research aimed at elucidating the nature, etiology, course,
and treatment of depression in young people. Accordingly,
scientiﬁc interest in these areas has proliferated dramati-
cally in the last decade (Nolen-Hoeksema and Hilt 2009).
However, despite an imperative to view depression from a
developmental psychopathology perspective (Cicchetti and
Schneider-Rosen 1984; Cicchetti and Toth 1998), much of
the knowledge on vulnerability to the disorder continues to
be framed by a simple and likely simplistic downward
extension of adult theories. As such, there is a need for
research in the area of child and adolescent depression to
more explicitly address two central principles of a devel-
opmental psychopathology framework: (1) The clear
articulation and examination of transactional models that
combine the roles of biological and environmental inﬂu-
ences and (2) the careful formulation of theories that take
into account how factors at various stages of development
operate within these models to shape pathways to affective
illness. Rather than simply characterizing how individuals
with and without depression differ on a given factor,
a developmental psychopathology perspective considers
ontology and trajectory: What is the origin of this associ-
ation and how does it unfold over time?
The Roles of Stress and the HPA Axis: Conceptual
Frameworks
One of the most fruitful and commonly cited lines of
inquiry from the adult depression literature comes from the
robust and often causal association between depression and
stress. Stress generation models have proven useful in
revealing the bidirectional, mutually perpetuating rela-
tionship between stress and depression (Hammen 1991,
1992). Brieﬂy, these models have highlighted the ways in
which depressed individuals may themselves contribute to
the generation or exacerbation of certain ‘‘dependent’’
stressors, particularly those occurring within the interper-
sonal context, as opposed to ‘‘independent’’ or more
apparently random events (e.g., a sudden loss or death in
the family). Additionally, a much larger and longer-
standing body of work has provided compelling evidence
that most episodes of major depression are temporally
preceded by stressful life events (e.g., Hammen 2005;
Kessler et al. 1997; Mazure 1998; Monroe and Hadjiyannakis
2002; Tennant 2002). For example, Mazure (1998) sum-
marized across empirical ﬁndings and concluded that acute
stressors were 2.5 times more likely to have been experi-
enced by depressed patients when compared with controls,
and 80% of depressive episodes among community sam-
ples developed subsequent to a major life event. Other
studies have underscored the possible distinctive impor-
tance of more chronic stress or ongoing ‘‘daily hassles’’ as
risk factors for depression, and some have argued that this
class of stressors represents even stronger predictors
(or drivers) of depressive symptoms than do acute stressors
(e.g., McGonagle and Kessler 1990).
An individual’s pattern of psychological and biological
reactions to stressors is often of equal or greater relevance
to the development of depression than are the stressors’
objective intensity or chronicity. Paralleling the research
demonstrating that depressed individuals report stronger
reactions to various stressors, decades of work investigat-
ing the pathophysiology of depression has revealed that
many depressed adults exhibit abnormal patterns of acute
responsiveness and/or chronic functioning in their stress
physiology (e.g., see Hankin and Abela 2005; Southwick
et al. 2005). Much of this work has focused on the hypo-
thalamic–pituitary–adrenal (HPA) axis, which, alongside
the sympathetic-adrenal-medullary (SAM) axis, is one of
the major biological stress response systems in humans.
Many of the hallmark symptoms of depression reﬂect
processes indicative of hypothalamic dysfunction, such
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motivation. Further still, the same neurotransmitters
implicated in the pathogenesis of depression (i.e., serotonin
and norepinephrine) are known to regulate the functioning
of the HPA axis (e.g., Feldman and Weidenfeld 1998; Klee
and Garﬁnkel 1984).
There have been many studies of the role played by the
HPA axis in the link between stress and depression. Over
the past 40 years, the literature has revealed that abnormal
HPA axis activity in adults with major depressive disorder
is among the most consistent and robust biological ﬁnding
in psychiatry to date (e.g., Halbreich et al. 1985; Rubin
et al. 1987; Stokes et al. 1984; see Chrousos and Gold
1992; Ehlert et al. 2001, for reviews). Adults with
depression disproportionately show chronic HPA axis
hyperactivity and an inability for this system to return to
normal functioning following a stressor (e.g., Young and
Korzun 1998). Indeed, at least 50% of depressed adults
show evidence of dysregulated HPA axis functioning
(American Psychiatric Association 1987; Nestler et al.
2002). Prolonged elevation in circulating cortisol levels can
result in exhaustion and irritability, which are classic
physiological symptoms of depression (Gurguis et al.
1990), and adults with the most severe depression also tend
to have the highest cortisol levels (Pruessner et al. 2003).
Thus, although not all individuals with elevated cortisol
levels are depressed, and not all depressed adults show
elevated cortisol, patterns of chronically dysregulated
HPA activity are highly over-represented in depressed
populations.
Less clear from the adult research is whether HPA axis
dysregulation is a consequence of stress experiences or a
pre-existing vulnerability. The former perspective is
reﬂective of models proposing that the activity of the HPA
axis changes in response to extreme and/or chronic stress
and that these changes might be part of the causal mech-
anisms by which environmental stress contributes to the
development of depression, the persistence of symptoms,
and the recurrence of the disorder (e.g., Nemeroff 1996;
Southwick et al. 2005). The latter hypothesis is that pre-
existing differences in HPA axis functioning may make
certain individuals more susceptible to the depressogenic
effects of stress (Holsboer 2000; van Rossum et al. 2006).
Both of these hypotheses implicitly highlight the impor-
tance of bringing a developmental perspective to study of
the role of adrenocortical regulation in depression.
Examining the developmental pathogenesis of child-
hood and adolescent depression would serve to broaden
understanding of depression across the lifespan. Given this,
it is somewhat surprising that there has been far less work
investigating the neurobiological correlates of depression
in young people (Kaufman et al. 2001). Indeed, until the
past decade, our understanding of the potential role of the
HPA axis in depression has been informed primarily by
research conducted on animals and adult humans. The
relative dearth of work conducted with children and ado-
lescents may be partially explained by an earlier reliance
on invasive procedures to assess HPA axis functioning
(e.g., blood draws through repeated venipunctures), but the
recent development of highly sensitive immunoassay
techniques has allowed for the accurate measurement of
cortisol from salivary samples. Such progress has facili-
tated the study of HPA axis functioning in a broader range
of populations (Klimes-Dougan et al. 2001).
There is a particular research imperative to begin map-
ping possible changes in HPA axis functioning among
depressed individuals at the transition to adolescence.
When compared with childhood, it has been well estab-
lished that adolescence is marked by signiﬁcant and rela-
tively abrupt increases in stressful life events (Ge et al.
1994; Larson and Ham 1993), particularly within the
interpersonal context (Rudolph and Hammen 1999). Fur-
ther, it has been found that adolescent girls are exposed to
both a higher number of interpersonal stressors and report
greater distress in response to them, when compared with
younger children and adolescent boys (Rudolph 2002;
Rudolph and Hammen 1999; Hankin et al. 2007). The
timing and nature of these dramatic rises in stressors
coincides with that of the equally alarming increases in
depressive symptomatology during adolescence, particu-
larly for girls; adolescence marks the period which initiates
the increasingly greater prevalence in the rates of depres-
sion in girls versus boys (e.g., Hankin et al. 1998; Twenge
and Nolen-Hoeksema 2002).
If HPA axis functioning plays a mechanistic role in
depression, it might be that pre-existing dysregulation
makes some youths vulnerable to the depressogenic effects
of stress or that the increase in stress disrupts HPA regu-
lation in some youths, which in turn initiates the progres-
sion of depressive symptoms. Early empirical examinations
of these proposals—chieﬂy conducted in the 1990s and
involving the examination of cortisol response to various
biological and psychological probes or the assessment of
basal cortisol levels—led some to conclude that the asso-
ciation between HPA axis dysregulation and pediatric
depression is weak or inconclusive at best (Birmaher et al.
1996a, b; Birmaher and Heydl 2001). More recent research,
however, has led some to the more nuanced conclusion that
the association appears to be stronger or weaker depending
upon which index of HPA functioning is examined and at
what age depression is manifested (Lopez-Duran et al.
2009; Kaufman et al. 2001).
With the explicit goal of applying a novel theoretical
perspective to the extant literature on the functioning of
various components of the HPA axis in depressed children
and adolescents, the sections below will correspond to the
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colleagues (2009) meta-analysis: (1) those examining the
HPA system’s response to the dexamethasone suppression
test (DST); (2) those assessing basal HPA axis functioning;
(3) those administering corticotropin-releasing hormone
(CRH) challenge; and (4) those incorporating psychologi-
cal probes of the HPA axis. In addition, attention will be
given to a ﬁfth category of studies: examinations of HPA
axis functioning in the offspring of parents with depression.
As much as possible within the constraints of available
data, a particular effort has been made to contextualize
these ﬁndings within a developmental psychopathology
framework. Principally, this necessitated the characteriza-
tion and comparison of both atypical and normative
developmental variations in HPA stress response across the
pubertal/adolescent transition (Cicchetti and Rogosch
2002). Accordingly, in addition to analyzing for method-
ological variations between studies that may be obscuring
potentially consistent ﬁndings, careful attention was paid to
possible differences in HPA system functioning between
depressed versus non-depressed samples and to the relative
degree and nature of these deviations across developmental
periods.
Overview of the HPA Axis
The HPA axis functions through the coordinated activity of
a series of organs within and outside the brain that pro-
duces a cascade of hormones resulting in the release of
cortisol from the adrenal glands (Chrousos and Gold 1992;
Kaltas and Chrousos 2007). Upstream is the hypothalamus,
wherein neurons in the paraventricular nuclei (PVN)
secrete corticotropin-releasing hormone (CRH) and argi-
nine vasopressin (AVP). When these reach the anterior
pituitary, they stimulate the corticotrophic cells to release
adrenocorticotropic hormone (ACTH). Blood-borne ACTH
circulates out of the central nervous system and reaches the
adrenal glands, located above the kidneys. There, ACTH
triggers the adrenal cortex to release corticosteroids,
including cortisol and dehydroepiandrosterone (DHEA),
into the circulatory system, where they are carried by the
blood to targets throughout the body to produce a variety of
effects.
One effect of cortisol is on the HPA axis itself. The HPA
axis is also a self-regulating system that decreases activity
through a negative feedback loop. Cortisol crosses the
blood–brain barrier and signals the hypothalamus to reduce
CRH production in the PVN. As less CRH is produced, the
pituitary gland decreases its production of ACTH, such that
the adrenal glands lose the signal to produce cortisol and
DHEA. This self-regulation is a critically adaptive feature
of the HPA axis that protects tissue from prolonged
exposure to elevated cortisol. Cortisol is a multifunctional
steroid that in the short-term supports coping with imme-
diate challenges and threats, but persistently elevated cor-
tisol levels—a condition called hypercortisolism—can lead
to a variety of harmful immunological, metabolic, and
psychological side effects.
The HPA axis is constantly active, to greater or lesser
degrees. Over the circadian cycle of day and night, or
waking and sleeping, normative cortisol production follows
a predictable pattern (Lovallo and Thomas 2000). The
normative pattern is for cortisol levels to be fairly high by
the end of the sleeping period and to continue increasing
until it peaks 30–40 min after awakening, called the cor-
tisol awakening response (CAR) (Adam et al. 2008; Chida
and Steptoe 2009). It is thought that the CAR evolved to
aid in preparing the body for rapid transition from night-
time quiescence to daytime activity. Circulating cortisol
levels then drop rapidly over the morning, drop more
slowly through the afternoon, and are at their lowest in the
evening (with temporary increases after eating meals,
Lovallo and Thomas 2000). Thus, over the waking (day-
time or diurnal) period, the change in cortisol levels is
characterized by a negative slope. Cortisol levels then
increase again during sleep, until the waking level is
reached in the morning hours. The diurnal rhythm consti-
tutes ‘‘baseline’’ or ‘‘basal’’ HPA activity, representing the
amounts of cortisol that would be expected to be circulat-
ing through the blood at a given time of day, all other
things being equal. Remarkably, this diurnal rhythm
becomes evident very early in development and can be
detected in infants a few months after birth (Gunnar and
Quevedo 2007). Yet there clearly are developmental
changes in HPA axis function, as it has been established
that basal cortisol levels rise over childhood and adoles-
cence (Gunnar et al. 2009a). Still, because there have been
few basic, descriptive studies of normative HPA axis
functioning in children, there is limited information on
age differences in typical levels of cortisol over the day
(Rosmalen et al. 2005).
Healthy HPA functioning also supports appropriate
responses to acute or discrete stressors by changing its
level of activity. The HPA axis triggers an increase in
circulating cortisol levels when a challenging or threatening
event occurs. Once the HPA axis begins ramping up its
response to a stressful event, it typically takes about 20 min
to reach peak levels of circulating cortisol (Gunnar and
Talge 2006; Kudielka et al. 2004). Depending on the
intensity and duration of the stressful event, it can take
longer for circulating cortisol to return to the baseline
expected for the time of day. Counterintuitively, whereas
the diurnal rhythm of cortisol is consistent across devel-
opment, there appears to be a curvilinear relation between
age and cortisol reactivity. The periods of preschool and
138 Clin Child Fam Psychol Rev (2011) 14:135–160
123childhood have been characterized as a time of hypore-
sponsivity of the HPA axis (Gunnar and Quevedo 2007;
Lupien et al. 2009). Compared with infants, adolescents,
and adults, children have been found to show much weaker
changes in cortisol production in response to psychosocial
stressors. It remains uncertain whether this reﬂects an
actual period of biological protection from the effects of
stress, possibly due to external regulation by parental care
(Lupien et al. 2009), or simply a methodological artifact of
researchers’ lack of success in designing and implementing
appropriate stressors to induce acute HPA axis responses in
children (Gunnar et al. 2009a). Either way, it is noteworthy
that the normative development of HPA axis activity
results in both higher basal cortisol levels and stronger
HPA axis responses to stressful events in adolescence,
when the frequency of life stressors and the prevalence of
depression also increase markedly.
The response of the HPA axis to chronic or pervasive
stressors, like poverty or family violence, is quite different
than its reactions to acute stressors. Stressful life conditions
seem to induce hypercortisolism. For example, children
living in socioeconomically impoverished homes have
been found to have higher cortisol levels in their basal
diurnal cycles (Lupien et al. 2000). Cortisol elevations that
are unusually prolonged can become deleterious (Kaltas
and Chrousos 2007; Lovallo and Thomas 2000), leading to
tissue catabolism, decreased immune function, and such
neuropsychological effects as lethargy and disrupted
emotional functioning. In fact, many of the side effects of
hypercortisolism are strikingly parallel to symptoms of
depression (Gurguis et al. 1990).
With this primer on the functioning of the HPA axis
system complete, we will now consider the evidence for
associations between HPA activity and depression in
children and adolescents.
The Dexamethasone Suppression Test
As a potent synthetic glucocorticoid, dexamethasone
functions to suppress the production of CRH by the
hypothalamus, as well as ACTH by the pituitary gland.
Hence, cortisol levels following the administration of
dexamethasone represent the sum of two opposing agents
acting on the HPA axis to modulate adrenal production of
the hormone: one to suppress cortisol’s secretion (e.g.,
endogeneous cortisol and exogenous dexamethasone) and
the other to stimulate it (e.g., exogenous stressors; Dahl
et al. 1992). Assuming the level of exogenous stress
remains constant, a normative response to orally adminis-
tered dexamethasone the night before leads to a profound
decrease in cortisol levels during the next day, while
incomplete levels of suppression or early escape from
suppression indicate dysregulation within the HPA axis’s
negative feedback mechanism (e.g., Burke et al. 2005;
Nicolson 2008). Such dysregulation appears to reﬂect tonic
HPA axis arousal and is usually considered an indication of
hypercortisolemia (Lopez-Duran et al. 2009).
The dexamethasone suppression test (DST) was origi-
nally applied in the late 1960s as a laboratory diagnostic
tool for major depression in adults (Carroll 1982; Carroll
et al. 1981). In the decades since, the DST has become the
most extensively studied biological parameter of depres-
sion in adult (Casat et al. 1989), as well as in child and
adolescent samples (Kaufman et al. 2001; Weller and
Weller 1988). In reviews of the use of the DST in adults, it
has been estimated that between 50 and 60% of depressed
inpatients and approximately 40% of outpatients have
abnormally high levels of cortisol (reﬂecting blunted sup-
pression) following the DST (APA 1987; Carroll 1982).
Although the diagnostic utility of the DST has been
questioned more recently due to its lower speciﬁcity in
inpatient samples (e.g., Dahl et al. 1989; Luby et al. 2003;
Pfeffer et al. 1989; Puig-Antich et al. 1989), its cumula-
tively high sensitivity led the American Psychiatric Asso-
ciation Task Force on Laboratory Tests in Psychiatry
(1987) to conclude that the test may add to diagnostic
reliability in adult patients suspected of having major
depressive disorder. Moreover, it has been argued that the
lack of speciﬁcity of the DST does not negate its clinical
relevance. Given that adult studies have consistently
demonstrated that heightened cortisol response to the DST
is associated with more severe depressive symptomatology,
it may serve as an index of clinical severity (e.g., Steingard
et al. 1990).
Approximately 30 studies to date have examined the
DST within samples of depressed children and adolescents
(see Table 1, an update and expansion of data previously
compiled by Kaufman et al. 2001). This still nascent and
heterogeneous literature can be summarized as follows.
First, about equal numbers of studies utilized samples of
prepubertal children and adolescents, and the majority of
these studies (77%) were conducted with psychiatric
inpatients. The remaining studies, which recruited depres-
sed participants referred either to outpatient evaluation or
to treatment, were mostly composed of children. Only two
studies by Birmaher et al. (1992b) and Dahl et al. (1992)
have conducted the DST with outpatient adolescents.
Second, the majority of studies utilized non-depressed
control groups which were nonetheless composed of indi-
viduals who met criteria for other psychiatric conditions.
Only six studies included normative control samples
(Birmaher et al. 1992a, b; Dahl et al. 1992; Fristad et al.
1988; Weller et al. 1985; Young et al. 2006). Third, the
vast majority of studies used a standardized experimental
protocol, namely the oral administration of dexamethasone
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Study MDD Control MDD measure Dose Collection
method/time
Non-suppressors Sensitivity
(%)
Speciﬁcity
(%)
Inpatient children
Livingston
et al. (1984)
3 MDD (1 pure, 2
comorbid with
DD, CD, etc.)
12 PC Dx assigned at
clinical case
conference
0.5 mg @
11 pm
Venipuncture
@ 4 p.m.
next day
2/3 MDD 4/6
ANX 1/1 SZ-S
0/3 CD 0/2
MISC
67 58
Petty et al.
(1985)
7 MDD (3 pure,
remainder
comorbid with
CD, aggressive
behavior, etc.)
23 PC ‘‘Consensus dx’’
assigned using
DSM-III
criteria;
KSADS-E
administered
for 60% across
all groups
0.5 mg @
11 pm
Venipuncture
@ 4 pm next
day, 2/3 of
all patients
also had
11 pm
venipuncture
6/7 MDD 4/5 DD
5/6 SZ-S 1/3 CD
2/3 ANX 1/6
MISC
86 43
Casat et al.
(1994)
11 MDD (unknown
comorbidity
status)
9 PC Dx assigned by
K-SADS-E
using DSM-III-
R criteria
2 trials:
0.5 mg @
11 pm on
Days 1 and
6
Venipuncture
@ 8 am and
4p mo n
Days 2 and 7
Day 2: 3/11 MDD
5/9 PC Day 7:
2/11 MDD 3/9
PC
27/18 44/66
Pfeffer et al.
(1989)
20 MDD (unknown
comorbidity
status)
31 PC Dx assigned by 2
independent
parent and child
K-SADS-P,
consensus dx
made using
DSM-III
criteria
0.5 mg @
11 pm
Venipuncture
@ 8 am, 4,
and 11 pm
next day
11/20 MDD 4/31
PC
55 87
Pfeffer et al.
(1989)
19 MDD (unknown
comorbidity
status)
As
above
As above 1 mg @
11 pm
As above 2/19 MDD 1/31
PC
11 97
Fristad et al.
(1988)
63 MDD (unknown
comorbidity
status)
14 PC
21 NC
DICA, CDI
administered
w/child and
parents
0.5 mg @
11 pm
Venipuncture
next day @
8 am and
4p m
Either time: 42/63
MDD 1/14 PC
2/21 NC
67 91
Naylor et al.
(1990)
14 MDD (unknown
comorbidity
status), 11 DD
48 PC ‘‘Consensus dx’’
assigned after
2 weeks of
hospitalization
based on DSM-
III criteria
0.5 mg @
11 pm
if\36 kg
1m g@
11 pm
if[36 kg
Venipuncture
@ 4 pm next
day
7/25 MDD ? DD
11/48 PC
28 77
Doherty et al.
(1986)
59 MDD (19 pure,
remainder
comorbid)
34 PC Dx assigned by
DSM-III
criteria
following
‘‘Standard
clinical
assessment’’
1m g@
11 pm
Venipuncture
next day @
8 am, 4 pm,
and 11 pm
15/34 MDD 4/19
DD 2/6 ADDM
1/15 ANX 0/4
CD 0/8 SZ-S 0/7
MISC
44 88
Weller et al.
(1984)
20 MDD (unknown
comorbidity
status)
N/A Unknown 0.5 mg @
11 pm
Venipuncture
next day @
8 am and
4p m
14/20 MDD 70 N/A
Freeman
et al. (1985)
5 MDD (comorbid
w/SZ-S)
N/A Child, parent
KSADS
0.5 mg @
11 pm
Venipuncture
next day @
4p m
4/5 MDD 80 N/A
Weller et al.
(1985)
50 MDD (unknown
comorbiditystatus)
18 PC
18 NC
DICA, DSM-III 0.5 mg @
11 pm
Venipuncture
next day @
8 am and
4p m
41/50 MDD 5/18
BD 2/18 NC
82 72 PC 89
NC
140 Clin Child Fam Psychol Rev (2011) 14:135–160
123Table 1 continued
Study MDD Control MDD measure Dose Collection
method/time
Non-suppressors Sensitivity
(%)
Speciﬁcity
(%)
Livingston
and Martin-
Cannici
(1987)
8 MDD (signiﬁcant
comorbid ANX)
12 ANX
12 BD
Child, parent
DICA
0.5 mg @
11 pm
Venipuncture
next day @
4p m
8/8 MDD 8/12
ANX 1/12 BD
100 63
Outpatient children
Young et al.
(2006)
3 MDD; Due to low
N only conducted
analyses with
grouped Dxs (3
MDD, 4 ANX, 3
ODD, 1 ADHD)
32 NC K-SADS 2 trials,
randomly
assigned:
0.5 mg @
‘‘bedtime’’
1m g@
‘‘bedtime’’
Saliva sample
next day
w/in 45 min
of
awakening,
4 pm, and
‘‘bedtime’’
Not reported Unknown Unknown
Steingard
et al. (1990)
27 MDD
(comorbidity
status unknown),
29
MDD ? ADHD
5 PC Clinical
interviews
conducted with
child/parent, all
dx based on
DSM-III
criteria
Weight
corrected
17 lg/kg
@1 1p m
Venipuncture
next day @
4p m
8/27 MDD 11/29
MDD ? ADHD
5/22 ADHD 0/5
PC
34 81
Birmaher
et al.
(1992a)
26 MDD
(comorbidity
status unknown)
10 PC 8
NC
2 independent
child and parent
KSADS-P,
MDD Dx
assigned by
RDC criteria,
control dx by
DSM-III
0.25 mg @
9p m
Indwelling
catheter: 24
hourly
samples
11/26 MDD 2/10
PC 6/8 NC
42 55 overall
80 PC 25
NC
Birmaher
et al.
(1992a)
23 MDD
(comorbidity
status unknown)
13 PC 9
NC
As above 0.5 mg @
9p m
As above 4/23 MDD 0/15
PC 5/8 NC
17 78 overall
100 PC
38 NC
Poznanski
et al. (1982)
9 MDD
(comorbidity
status unknown)
9 PC Dx assigned by
‘‘case
conference
consensus’’
after parent and
child KSADS
0.5 mg @
11 pm
Venipuncture
next day @
4p m
5/9 MDD 1/9 PC 56 89
Geller et al.
(1983)
14 MDD (9
comorbid for
antisocial
behavior or ANX)
N/A KSADS-P
according to
RCD and DSM-
III
Weight
corrected
20 lg/kg
@
11:30 pm
Venipuncture
next day @
4p m
2/14 MDD 14 N/A
Inpatient adolescents
Extein et al.
(1982)
15 MDD (all
‘‘pure’’)
12 PC Semistructured
interviews, Dx
assigned by
DSM-III
criteria for
MDD
1m g@1 2
am
Venipuncture
next day @
8 am, noon,
4 pm, and
midnight
8/15 MDD 1/12
PC
53 92
Hsu et al.
(1983)
14 MDD (unknown
comorbidity
status)
79 PC Semistructured,
standardized
intake
interview, chart
review
according to
DSM-III
criteria
1m g@
11 pm
Venipuncture
next day @
4 pm and
11 pm
9/14 MDD 2/6
ADDM 0/2 DD
4/26 CD 2/8 SZ-
S 6/10 ED
64 68
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123Table 1 continued
Study MDD Control MDD measure Dose Collection
method/time
Non-suppressors Sensitivity
(%)
Speciﬁcity
(%)
Robbins et al.
(1983)
16 MDD (unknown
comorbidity
status)
12 PC ‘‘Consensus dx’’
according to
RDC criteria
based on
K-SADS,
Hamilton
Rating Scale
1m g@
11 pm
Venipuncture
next day @
8 am, 4 pm,
11 pm
4/16 MDD 0/12
PC
25 100
Ha et al.
(1984)
26 (22 MDD, 4 w/
’’minor depressive
d/o’’)
16 PC Adolescent and
parent KSADS
1m g@
11:30 pm
Venipuncture
next day @
4 pm and
11 pm
7/22 MDD 2/4 DD
3/16 PC
32 75
Targum and
Capodanno
(1983)
17 MDD (unknown
comorbidity
status)
103 PC Dx assigned
according to
DSM-III
criteria using
clinical
interview
1m g@
11:30 pm
Venipuncture
next day @
4p m@
11:30 pm
7/17 MDD 7/38
DD 7/47 CD
4/15 SZ-S
41 82
Robbins et al.
(1982)
4 MDD 5 PC 2 independent
KSADS,
consensus dx
according to
RCD criteria
1m g@
11:30 pm
Venipuncture
next day @
8 am, 4 pm,
11 pm
2/4 MDD 0/5 PC 50 100
Klee and
Garﬁnkel
(1984)
20 MDD (unknown
comorbidity
status)
13 PC KSADS dx
according to
RDC criteria
1m g@
11 pm
Venipuncture
next day @
8 am, 4 pm,
11 pm
8/20 MDD 1/13
PC
40 92
Emslie et al.
(1987)
33 MDD
(predominantly
comorbid)
18 DD
35 PC
Dx assigned
according to
DSM-III
criteria using
semistructured
interview
w/patients and
parents
0.5 mg for
children
(\Tanner
3), 1 mg
for
adolescents
Venipuncture
next day @
4p m
18/33 MDD 4/18
DD 4/35 PC
55 89 (PC)
Woodside
et al. (1987)
10 MDD (unknown
comorbidity
status)
18 CD 2
BP
Consensus
diagnosis
according to
DSM-III
1m g@
11 pm
Venipuncture
next day @
4 pm and
11 pm
8/10 MDD 2/18
CD 2/2 BP
80 80
Khan (1987) 33 MDD
(predominantly
comorbid)
22 CD 6
DD 5
ADHD
Semistructured
interview
according to
DSM-III
1m g@
11 pm
Venipuncture
next day @
4 pm and
11 pm
23/33 MDD 3/22
CD 1/6 DD 1/5
ADHD
70 85
Evans et al.
(1987)
20 MDD (unknown
comorbidity)
32 PC Semi-/un-
structured
interview with
patient and
family
members
according to
DSM-III
criteria
1m g@
11 pm
Venipuncture
next day @
4 pm and
11 pm
8/20 MDD 5/32
PC
40 84
Appelboom-
Fondu and
Kerkhofs
(1988)
8 MDD (comorbid
with bipolar)
12 PC KSADS
according to
RDC criteria
1m g@
9p m
Venipuncture
next day @
2 and 9 pm
4/8 MDD 0/12 PC 50 100
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123to depressed participants and non-depressed controls at or
around 11 p.m., and cortisol levels were measured with
single or repeated blood draws at various times during the
subsequent day. Fourth, almost without exception, cortisol
‘‘non-suppression’’ (i.e., an abnormal DST result) was
deﬁned according to the categorical adult criterion rec-
ommended by Carroll and colleagues (1968; i.e., an
unbound plasma cortisol level C 5 lg/dl at any time dur-
ing the ﬁrst day post-dexamethasone administration).
A wide range of variability in DST results was found
across individual studies, likely due to the large number of
studies using small samples sizes. Indeed, approximately
half of these published reports included only 15 or fewer
depressed children or adolescents and a comparably small
number of non-depressed control participants. Important
trends are apparent, however, when considering these ﬁnd-
ings in aggregate. Most salient and consistent with the
overall meta-analytic ﬁnding based on the smaller set of
studies reported by Lopez-Duran et al. (2009), depressed
children and adolescents demonstrated greater cortisol pro-
duction (or less suppression) after the DST when compared
with non-depressed controls. In averaging across all studies,
approximately 45% of depressed children and adolescents
and only 18% of non-depressed control participants had
positive DST results. This overall rate of cortisol non-sup-
pression among juvenile depressed samples (compiled of
results from child, adolescent, as well as from inpatient and
outpatientsamples)iscomparabletothatreportedinsamples
of depressed adults (APA 1987). Thus, these data suggest
that abnormal HPA axis functioning as measured by cortisol
non-suppression following the DST is associated with at
leastsomeformsofchildandadolescentdepression.Further,
given the psychobiological mechanisms purportedly mea-
suredbytheDST,thisdysregulationsupportsthehypothesis
that the HPA axis of some young people with depression is
hyperactiveduetoeitherinsensitivitytoorearlyescapefrom
the system of hormonal ‘‘brakes’’ that, in normative popu-
lations, has evolved to return the HPA stress system to
homeostasis following a stressful precipitant.
Also consistent with a robust ﬁnding from the adult DST
literature, the rates of cortisol non-suppression in inpatient
depressed children and adolescents were approximately
double those found in outpatient samples. This pattern is
unsurprising. Assuming that inpatients as a group tend to
be individuals with more serious forms of psychopathol-
ogy, dysfunction, and impairment than their outpatient
counterparts, it is intuitive that greater HPA axis dysreg-
ulation might be present among more severely depressed
young people. As noted above, parallel evidence for this
contention can be found in the adult data; severe MDD
patients showed greater post-DST non-suppression than did
those with less symptomatology (APA 1987). Unfortu-
nately, this hypothesis cannot be directly examined within
individual studies conducted with child and adolescent
samples, much less between samples of inpatients and
outpatients. Most DST studies conducted with young
people relied on assessment methods that assigned a simple
categorical diagnosis of depression based on clinician-
administered, semistructured interviews. Only Birmaher
et al. (1992a, b) conducted analyses of supplementary,
continuous data related to the severity of depression among
their sample of adolescent outpatients. However, these
investigators reported unexpected results; adolescents who
scored higher on the self-reported Hamilton Rating Scale
Table 1 continued
Study MDD Control MDD measure Dose Collection
method/time
Non-suppressors Sensitivity
(%)
Speciﬁcity
(%)
Outpatient adolescents
Birmaher
et al.
(1992b)
44 MDD (Unknown
comorbidity
status)
38 NC 2 independent
K-SADS
administered,
HAM-D,
According to
RDC criteria
for MDD
1.0 mg @
11 pm
Indwelling
catheter:
hourly
samples next
day from 8
am - 11 pm
6/44 MDD 1/38
NC
14 97
Dahl et al.
(1992)
27 MDD
(signiﬁcant
comorbidity)
34 NC 2 independent
parent and child
KSADS-P, dx
based on RDC,
DSM-III
criteria
1m g@
11 pm
Indwelling
catheter:
hourly
samples next
day from 8
am - 11 pm
4/27 MDD 3/34
NC
15 91
ADDM adjustment disorder with depressed mood, ADHD attention-deﬁcit/hyperactivity disorder, ANX anxiety disorders, BD behavior disorders
(oppositional deﬁant disorder, ADHD with hyperactivity, conduct disorder), BP bipolar disorder, CD conduct disorder, DD dysthymic disorder,
ED eating disorders, MDD major depressive disorder, MISC miscellaneous diagnoses, NC normative controls, ODD oppositional deﬁant
disorder, PC psychiatric controls, SZ-S schizophrenia spectrum
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123for Depression (HAM-D; Hamilton 1960) had a lower rate
of non-suppression following the DST (Birmaher et al.
1992a, b).
Of more direct relevance to viewing the association
between depression and HPA axis dysregulation through a
developmental psychopathology perspective, the available
DST data allow for a preliminary comparison of the rates
of cortisol non-suppression among children versus ado-
lescents. Ostensibly contrary to the expectations of theo-
retical models proposing progressive HPA axis dysfunction
across development consequent to recurrent stress exposure
(e.g., Southwick et al. 2005), the rates of non-suppression
were observed to be somewhat higher among children than
among adolescents. An estimated 50–70% of depressed
children and 40–60% of depressed adolescents were found
to have abnormally high levels of cortisol subsequent to the
DST (Kaufman et al. 2001).
However, a potentially confounding methodological
factor must be considered in the interpretation of these
unexpected data. Critically, the dose of dexamethasone
most frequently used in studies with children was 0.5
milligrams, while the standard, adult dose of 1.0 milligrams
was used in all studies with adolescents. It is possible, as
some have argued (e.g., Dahl et al. 1992; Pfeffer et al.
1989), that it is unwarranted and misleading to use the
1-mg, adult-equivalent dose of dexamethasone with ado-
lescents. Administering dexamethasone to adolescents at
double the milligrams of the typical child dose might not
be proportionate to the increase in body mass and/or
metabolism expected across this period of development.
One possible result of an overly high dose of dexametha-
sone could be the uniform suppression of cortisol regard-
less of diagnostic status.
Pfeffer et al. (1989) found compelling empirical support
for the importance of using the ‘‘appropriate’’ dose of
dexamethasone among preadolescents. In conducting the
DST with children at the threshold of adolescence, these
investigators found that the 0.5-mg dose was more sensi-
tive (i.e., correctly identiﬁed a greater proportion of
depressed individuals) than the 1-mg dose. Accordingly,
the pattern of slightly higher rates of non-suppression
observed among child relative to adolescent samples may
reﬂect a systematic difference in the dose of dexametha-
sone used between age groups, rather than any develop-
mental differences in HPA axis functioning. Future work
comparing child and adolescent response to the DST would
beneﬁt from the consistent (or, best, physically propor-
tionate) application of dexamethasone dose. Naylor et al.
(1990), for example, suggested that dosage might be better
calculated as a proportion of body surface area.
A ﬁnal and considerable limitation of the extant litera-
ture examining the DST among pediatric samples pertains
to the generally ambiguous diagnostic classiﬁcation of
participants. Many studies reportedly utilized rigorous
diagnostic procedures such as repeated, multi-informant,
semistructured clinical interviews to diagnose MDD based
on DSM or RDC criteria (e.g., Birmaher et al. 1992a, b;
Dahl et al. 1992; Pfeffer et al. 1989; Robbins et al. 1982).
However, the majority of studies either made no explicit
attempt to characterize (let alone control for) the possible
comorbid status of depressed participants, or—when
comorbidities were determined—simply defaulted to major
depression as the primary diagnosis. Thus, as has been
argued in the adult DST literature (Zimmerman et al.
1986), DST studies conducted with children and adoles-
cents are seriously limited by a failure to account for the
diagnostic heterogeneity of depressed participants.
Basal Cortisol Functioning and Diurnal Variation
As mentioned above, studies conducted with depressed
adults have consistently demonstrated that a substantial
proportion of these adults hypersecrete cortisol across
various measured indices of basal HPA axis functioning.
For example, when compared with non-depressed controls,
depressed adults tend to exhibit higher mean 24-h plasma
levels of cortisol, increased frequency of cortisol secretion
episodes, greater magnitudes of cortisol released during
each pulse, an earlier time of cortisol rise during sleep, and
an overall loss of the usual circadian rhythm (Christensen
et al. 1985; Halbreich et al. 1985; Jarrett et al. 1983;
Linkowski et al. 1985; Mortola et al. 1987; Pfohl et al. 1985,
b;Rubinetal.1987;Sacharetal.1973;Stokesetal.1984;for
reviews see Stokes and Sikes 1991; Barden 2004).
As with the body of work investigating the DST, basal
cortisol secretion and diurnal rhythms associated with child
and adolescent depression are similarly incomplete. The 20
studies conducted to date in this area are summarized in
Table 2, which is an adaptation and expansion of data
previously presented by Lopez-Duran et al. (2009). Here
again, approximately equal numbers of published reports
utilized child and adolescent samples. The average sample
size in studies of diurnal cortisol is larger than that of
studies of response to DST, but about half the studies
included fewer than 40 patients with depression and a
comparable number of control participants. In contrast to
the DST literature, all but four studies of child and ado-
lescent basal HPA axis functioning included normative
control samples. A synthesis of ﬁndings across this pre-
liminary research is difﬁcult due to the wide array of basal
cortisol measures that have been indexed (e.g., mean 24-h
composite, overall peak/nadir, time of nocturnal rise,
individual samples collected at different predetermined
times during the day) and the disparate biological samples
that were assayed (e.g., blood, saliva, urine). For example,
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123Table 2 Studies of basal cortisol functioning in children and adolescents
Study Sample MDD Control MDD measure Collection method/
time
Nighttime
cortisol
Daytime and/or
total cortisol
Pfeffer
et al.
1989
Inpatient
children
20 MDD (unknown
comorbidities)
19 DD 9 SZ-S
3 Neither
Dx assigned
according to
DSM-III criteria
based on 2
independent
K-SADS-P with
parents and
children
Venipuncture @ 8
am, 4, and 11 pm
Equivalent Equivalent
Casat
et al.
(1994)
Inpatient
children
11 MDD (unknown
comorbidities)
9 PC Dx assigned
according to
DSM-III criteria
based on
K-SADS-E
Venipuncture @ 8
AM on two
separate days
N/A Lower
Birmaher
et al.
(1996)
Both inpatient
and
outpatient
children
34 MDD (unknown
comorbidities)
22 NC Dx assigned
according to
RDC based on
parent and child
K-SADS-P and
K-SADS-E
Indwelling venous
catheter; samples
taken 30, 15, 0 min
before 9 am CRH
infusion
N/A Equivalent
Kaufman
et al.
(1997b)
Both inpatient
and
outpatient
children
13 MDD abused 13
MDD non
13 NC Dx assigned
according to
RDC based on 2
independent
K-SADS
Indwelling venous
catheter: samples
taken at 30, 15, and
0 min pre- CRH
infusion
N/A Equivalent
Birmaher
et al.
(1992b)
Outpatient
children
23 MDD (15
endogenous, 6
psychotic, 18
suicidal)
13 PC 9 NC Dx assigned
according to
DSM-III (PC) or
RDC criteria
(MDD) based on
2 independent
parent and child
KSADS-P
Indwelling catheter:
24 hourly samples
beginning 9 PM
Equivalent Equivalent
Feder
et al.
(2004)
Outpatient
children
76 MDD (unknown
comorbidities)
31 ANX 17
NC
Dx assigned
according to
RDC criteria
based on 2
independent
K-SADS-P
Indwelling venous
catheter: hourly
blood samples
collected over
24-hr period
Equivalent Equivalent
Luby
et al.
(2003)
Outpatient
preschoolers
55 MDD (unknown
comorbidities)
43 PC 57 NC Parent DISC
(modiﬁed to be
developmentally
appropriate)
Saliva samples
collected on 3
consecutive nights
Equivalent N/A
Forbes
et al.
(2006)
Outpatient
children and
adolescents
116 MDD
(unknown
comorbidities)
32 ANX 76
NC
Dx assigned by
case conference
consensus based
on K-SADS-PL
Indwelling venous
catheter:
daytime = 40, 20,
and 0 min before
CRH infusion;
nighttime = every
20 min beginning
2 h before
individual bedtime
Higher than
NC
N/A
Puig-
Antich
et al.
(1989)
Outpatient
children
45 MDD (unknown
comorbidities)
20 PC 8 NC Dx assigned
according to
RDC criteria
based on 2
independent
K-SADS-Ps
Indwelling venous
catheter: samples
every 20 min for
24 h
Equivalent Equivalent
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Study Sample MDD Control MDD measure Collection method/
time
Nighttime
cortisol
Daytime and/or
total cortisol
Doherty
et al.
(1986)
Inpatient
children and
adolescents
43 MDD
(signiﬁcant
comorbidity)
29 PC Dx assigned
according to
DSM-III criteria
following
‘‘Standard
clinical
assessment’’
Venipuncture @ 8
am and 11 pm.
Equivalent Equivalent
Goodyer
et al.
(1996)
Outpatient
children and
adolescents
82 MDD (unknown
comorbidities)
11 PC 40 NC Dx assigned
according to
DSM-III-R
criteria based on
K-SADS-P
Salivary cortisol
samples at 8 AM,
12 PM, 8 PM over
2 consecutive days
Higher than
both PC, NC
Equivalent
Extein
et al.
(1982)
Inpatient
adolescents
15 MDD (unknown
comorbidities)
12 PC Dx assigned
according to
DSM-III criteria
based on
semistructured
interviews
Venipuncture @
4 pm, midnight,
and 8 am.
Equivalent Equivalent
Kutcher
et al.
(1991)
Inpatients
adolescents
12 MDD (unknown
comorbidities)
12 NC Dx assigned
according to
DSM-III-R
criteria based on
K-SADS
Indwelling venous
catheter: samples
at 10 PM, 12 AM,
1, 2, 3, 4, and 6
AM
Equivalent Equivalent
Dahl et al.
(1991)
Inpatient and
outpatient
adolescents
27 MDD
(‘‘signiﬁcant
comorbidity’’)
32 NC Dx assigned
according to
adult RDC
criteria based on
2 independent
K-SADS-Ps
Indwelling venous
catheter: blood
draws every
20 min for 24 h
(starting 8:30 AM)
Higher Equivalent
Rao et al.
(2008)
Outpatient
adolescents
30 MDD (unknown
comorbidities)
25 NC Dx assigned
according to
DSM-IV criteria
based on
adolescent and
parent K-SADS-
PL
Saliva samples
collected at 30 min
intervals for 2 h
(i.e., 5 samples)
N/A Equivalent
Dahl et al.
(1989)
Outpatient
adolescents
48 MDD (unknown
comorbidities)
40 NC Dx assigned
according to
adult RDC
criteria based on
2 independent
K-SADS-Ps
Indwelling venous
catheter: blood
samples every
20 min for 24 h
Equivalent Equivalent
Rao and
Poland
(2008)
Outpatient
adolescents
16 MDD (unknown
comorbidities)
16 NC Dx assigned
according to
DSM-IV criteria
based on
adolescent and
parent K-SADS-
PL
Nocturnal urinary
free cortisol
(10:30 pm and 7
am samples)
Higher N/A
Mathew
et al.
(2003)
a
Outpatient
adolescents,
in 10 year
follow-up
study
48 MDD at Time 1;
56 MDD at Time
2 (15 with
comorbid anxiety
disorder)
21 NC Dx assigned
according to
SADS-LA
according to best
estimate
procedure
Indwelling venous
catheter; blood
samples every
20 min for 24 h
(starting in the
A.M.)
Equivalent, but
LOWER in
subsequently
suicidal
outpatients
Equivalent, but
HIGHER in
subsequently
suicidal
outpatients
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123nine studies employed the use of an indwelling venous
catheter to collect unbound plasma cortisol samples from
blood at various, unstandardized times throughout the day,
whereas seven studies collected samples either from repe-
ated venipuncture or from saliva. Assays of saliva samples
assess only the levels of unbound (active) cortisol, whereas
assays of serum assess both unbound and bound (inactive)
cortisol. However, there is high correspondence between
serum and saliva assays of cortisol in children (Bober et al.
1988; Burke et al. 1985; Schwartz et al. 1998), and results
of studies using the two procedures are generally
convergent.
Further complicating a systematic comparison of results
between depressed and non-depressed children and ado-
lescents across studies is the well-known and substantial
inter- and intra-personal variability in daily cortisol pro-
duction due to a number of variables. For instance, not only
are basal levels thought to represent individual differences
in temperamental or trait dimensions (e.g., Stansbury and
Gunnar 1994), but particular diurnal patterns of cortisol
secretion vary as a function of an individual’s usual cir-
cadian sleep–wake cycle (e.g., Nicolson 2008). Likewise,
given that sleep disruption is a criterial symptom of the
diagnosis of major depression, it is certainly possible that
systematic group differences exist in the sleep-wake cycles
of depressed versus non-depressed young people. Thus, to
control for these group and individual differences and
enable meaningful comparison of data between depressed
and non-depressed samples, it is arguably necessary to
analyze diurnal cortisol trajectories aligned by time of
sleep onset rather than by objective clock times (e.g.,
Klimes-Dougan et al. 2001). Seven of the studies presented
in Table 2 (Adam et al. 2010; Dahl et al. 1989, 1991;
Forbes et al. 2006; Goodyer et al. 2003; Mathew et al.
2003; Puig-Antich et al. 1989) accounted for these possible
confounders. It may be important to note, at least anec-
dotally, that of the eight studies from Table 2 that found
any evidence for differences in basal cortisol levels
between depressed patients and controls, four (Adam et al.
2010; Dahl et al. 1991; Forbes et al. 2006; Mathew et al.
2003) took additional steps to conduct analyses that
accounted for time of sleep onset.
Methodological and biological heterogeneity notwith-
standing, several important patterns emerge from results
found across studies of HPA basal functioning. First, the
majority of published reports failed to detect statistically
signiﬁcant differences between depressed and control
youths on any measure of basal cortisol secretion. More
speciﬁcally, and contrary to reliable ﬁndings in the adult
data, none of the studies conducted with children and
Table 2 continued
Study Sample MDD Control MDD measure Collection method/
time
Nighttime
cortisol
Daytime and/or
total cortisol
Goodyer
et al.
(2003)
b
Outpatient
adolescents,
in 2 year
follow-up
study
30 MDD (19 RMD,
11 PMD)
30 NC (high
risk, never
depressed)
Dx assigned
according to
DSM-IV criteria
based on the
Kiddie-SADs
patient version
Salivary cortisol
samples at 8 A.M.
and 8 P.M. over 4
consecutive days
Equivalent Equivalent, but
higher morning
cortisol:DHEA
ratio in PMD
Adam
et al.
(2010)
c
Outpatient
adolescents,
in 1 year
follow-up
study
40 past MDD and
16 current MDD
at Time 1; 18
MDD at Time 2
(9 recurrences, 9
new cases); 20
with subclinical
MDD at Time 2.
192 NC
(over-
sampled for
high
neuroticism)
Dx assigned
according to the
DSM-IV (SCID)
Salivary cortisol
samples gathered 6
times per day over
3 consecutive
weekdays: at
wake-up, 40 min
after waking, at 3,
8, and 12 h post-
awakening, and at
bedtime.
Equivalent Higher (Car)
ANX anxiety disorders, DD dysthymic disorder, MDD major depressive disorder, NC normal controls, PC psychiatric controls, SZ-S schizo-
phrenia spectrum disorders, RMD remitted major depression, PMD persistent major depression, CAR cortisol awakening response
a Groups were further split into: MDD T1 Suicide (attempts prior to T1), MDD T10 Suicide (attempts between T1 and follow up), and MDD No
Suicide. MDD T10 showed elevated cortisol levels prior to sleep onset (afternoon, evening, night). MDD T10 also showed elevated cortisol
levels 100 min prior and 100 min after sleep onset, but lower levels of cortisol secretion 2-4 h after sleep onset
b Youths with MDD that persisted over 24 months had higher cortisol:DHEA ratios in morning saliva samples than at-risk youths without
depression, and at-risk youths who had MDD at 12 months follow-up but remitted by 24 months
c Study also used CAR (cortisol awakening response) information as predictor of later onset of MDD, and found that individuals who had higher
levels of cortisol in their CAR were more likely to become MDD by follow-up. For these purposes, the 56 baseline MDD participants were
excluded from that part of the study
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123adolescents found signiﬁcant differences between groups
of depressed and control youths on any of the following
basal cortisol summary variables: 24-h mean level, over-
all peak, daytime mean, pulse frequency, or pulse
amplitude.
It is interesting to note, however, that overall non-sig-
niﬁcant trends of cortisol hypersecretion were often found
among samples of depressed young people. It is certainly
plausible that the aforementioned small samples sizes
typically utilized throughout this literature seriously lim-
ited the power of any individual study to detect more subtle
deviations from normative diurnal pattern of cortisol pro-
duction. Indeed, signiﬁcant basal elevations appeared to be
more often reported by those studies with larger samples
sizes (i.e., Dahl et al. 1991; Forbes et al. 2006; Goodyer
et al. 1996). This argument is further strengthened by the
positive result of a recent meta-analysis that revealed a
statistically signiﬁcant tendency for depressed children and
adolescents to have higher basal cortisol levels relative to
non-depressed controls (Lopez-Duran et al. 2009).
Intriguingly, Lopez-Duran et al. (2009) also found that age
did not moderate this association; cortisol levels were
similarly elevated in depressed prepubertal children and
depressed adolescents. This is somewhat surprising, given
that the association between dysregulation of basal cortisol
secretion and depression appears to be more robust in
adults. It is worth noting, though, that one of the few
studies to directly and carefully compare the HPA axis
activity of depressed children and adolescents found that
only depressed adolescents had elevated cortisol levels in
the period preceding sleep onset (Forbes et al. 2006). Thus,
there may be a pattern in which pediatric depression
becomes increasingly linked to basal HPA axis dysfunction
with advancing age.
Interestingly, Casat et al. (1994) conducted the only
study that found evidence for reduced cortisol secretion
among depressed children. However, there are certain
distinguishing characteristics of this study that may
account for these divergent results. These investigators
utilized a methodology distinct from the majority of other
studies of basal cortisol levels and patterns, and they
included the smallest number of depressed participants
(i.e., n = 11) of any study examining basal HPA axis
functioning in this age group. Taken together, these limi-
tations raise the possibility that these aberrant results are
spurious.
Perhaps most revealing, though, are the three longitu-
dinal studies on the relations between HPA axis function
and adolescent depression (Adam et al. 2010; Goodyer
et al. 2003; Mathew et al. 2003). All three involved the
measurement of cortisol levels in adolescents with and
without depression and the prediction of youths’ sub-
sequent mental health one to 10 years later. Goodyer et al.
(2003) compared morning and evening salivary cortisol
and DHEA levels in 60 adolescents at high risk for
developing MDD but who had not manifested any disorder.
They conducted diagnostic interviews at two follow-ups,
12 and 24 months later. Of note, these investigators
examined youths’ cortisol:DHEA ratios; because DHEA
has neuroprotective properties and is an antagonist to the
actions of cortisol, this ratio provides an indicator of
functional hypercortisolism. Goodyer and colleagues found
that having higher cortisol: DHEA ratios predicted youths’
development of persistent MDD, present at both 12- and
24-month follow-ups, compared with youths who did not
develop MDD and youths with MDD at 12 months that
subsequently remitted.
Mathew et al. (2003) used continuous blood sampling to
study 24-h cortisol cycles in 42 adolescents with MDD and
35 without and examined these youths again 10 years later
with the goal of predicting suicide attempts. Although
cortisol levels had not distinguished the youths with and
without depression in concurrent analyses (Dahl et al.
1989), cortisol rhythms predicted trajectories toward
suicidality. Compared with all other young adults, the 13
youths with lifetime diagnoses of MDD who attempted
suicide in the subsequent 10 years had elevated cortisol
levels in the 6 h before sleep onset, from late afternoon
through evening. They also had lower cortisol levels 2–4 h
after sleep onset when, normatively, the HPA axis would
be expected to increase cortisol production. Thus, a sys-
temic dysregulation of diurnal HPA axis activity predicted
subsequent suicidal behavior in young people with
depression.
Finally, Adam et al. (2010) assessed depression symp-
toms and collected saliva samples to measure the CAR in
230 17-year-old youths, many of whom had high levels of
neuroticism, a risk factor for depression (Kendler et al.
2004), and again measured symptoms of depression one
year later. Those young adults who had highly elevated
CAR a year earlier were three times more likely to have
developed MDD, compared to average. Earlier high CAR
predicted subsequent MDD even after the researchers took
account of the youths’ original symptoms of depression and
anxiety, their experiences of stressful life events, and other
potentially confounding factors.
Together, these three studies offer strong evidence that
dysregulated basal HPA activity precedes and predicts the
development of depression and associated behaviors in
adolescence and early adulthood. As suggested in the meta-
analysis by Lopez-Duran et al. (2009), this does not appear
to be due to dysregulation at any speciﬁc part of the diurnal
rhythm. Rather, exaggerated CAR, elevated morning and
evening cortisol, and lower cortisol after sleep onset all
appear to characterize youths who are at greater risk for
developing depression.
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The chain of physiological activation of the HPA axis
begins far upstream in the hypothalamus with the release of
CRH, ultimately leading to the release of cortisol and
DHEA (for review, see Sapolsky et al. 2000). Given the
central role of CRH as the driver for this sequence of
activation, some investigators have hypothesized that the
cortisol-related abnormalities observed among depressed
adults may be due to enhanced secretion of CRH (Gold
et al. 1986; Plotsky et al. 1998). This led to several
investigations examining patients’ ACTH and cortisol
responses to the administration of exogenous CRH in a
laboratory setting. This research, which has almost exclu-
sively relied on adult samples, has repeatedly demonstrated
that depressed individuals tend to have elevated cortisol
and blunted ACTH secretion in response to CRH infusion,
relative to normal controls (see Birmaher et al. 1996b, for a
review). ACTH secretion is hypothesized to be attenuated
due to a gradual downregulation of pituitary CRH receptors
over time in response to chronically increased hypotha-
lamic CRH secretion and/or the loss of fast feedback reg-
ulation in the hypothalamus or hippocampus (Ronsaville
et al. 2006). Accordingly, a normal cortisol response to
blunted ACTH secretion is evidence of HPA axis dysreg-
ulation in the form of a hyper-responsive adrenal cortex
(see Gold et al. 1995).
Surprisingly, only four studies have compared cortisol
and ACTH responses between samples of depressed and
non-depressed children and adolescents following CRH
challenge (Birmaher et al. 1996b; Dorn et al. 1996;
Kaufman et al. 1997a, b; Ronsaville et al. 2006). In contrast
to the adult data, none of these studies found signiﬁcant
differences in overall cortisol or ACTH secretion between
depressed and non-depressed groups of children (Birmaher
et al. 1996b; Kaufman et al. 1997a, b; Ronsaville et al.
2006) or adolescents (Dorn et al. 1996). With the exception
of the study conducted by Ronsaville et al. (2006), which
reported results based on only six actively depressed chil-
dren, null ﬁndings across the remainder of CRH studies
were reported despite sample sizes which included 20 or
more depressed children or adolescents and a comparable
number of non-depressed control participants.
Nonetheless, a closer examination of the scarce litera-
ture on CRH in the young suggests important directions for
further investigation. If these replicated the albeit limited
historical data, they would establish continuities with the
adult data. For example, Birmaher et al. (1996b) found that
depressed inpatient children exhibited signiﬁcantly lower
total ACTH secretion after CRH infusion relative to
depressed outpatients, while still maintaining comparable
cortisol reactivity. Similar to the ﬁndings in adults, it is
possible that some depressed young people may manifest
HPA axis dysregulation through adrenal cortex hyper-
responsivity. Such evidence, however preliminary, is also
in accord with a salient pattern found in DST studies,
namely the pronounced differences in HPA axis function-
ing between inpatients and outpatients. Birmaher et al.
(1996b) hypothesized explanations for group differences in
total ACTH secretion following CRH infusion also parallel
DST ﬁndings. First, their suggestion that the depressed
inpatients in their sample may have been more severely
depressed than the outpatient subgroup was not supported
by secondary analyses that revealed no signiﬁcant group
differences between inpatients and outpatients on either the
Hamilton Depression Rating Scale or the depression
module from the K-SADS-P. Therefore, the explanation for
the observed group differences in total ACTH secretion
was considered to lie in increased (but unmeasured) levels
of exposure to and/or perception of stress experienced by
inpatients before and during the ﬁrst days of hospitaliza-
tion. Such hypotheses remain speculative and signiﬁcant
questions remain as to how to account for possible group
differences in CRH studies between inpatient and outpa-
tient samples of depressed young people. It may be that
inpatient status serves as a proxy for greater stress expo-
sure, more severe depressive symptomatology, chronicity
of the disorder, and/or some combination of these factors.
Likewise, the study conducted by Kaufman et al.
(1997a, b) allowed for interesting analyses of subgroup
data with possible developmental implications. These
investigators examined the results of CRH challenge
among samples of depressed abused and depressed non-
abused outpatient children, as well as age-matched normal
controls. Although no differences in cortisol secretion were
found post-CRH infusion between groups, one group of
children differed signiﬁcantly—and in the unexpected
direction—with regard to their subsequent ACTH levels.
When compared with depressed children without a history
of abuse and control children, depressed abused children
had signiﬁcantly higher peak, total, and net ACTH secre-
tion post-CRH challenge. Exploratory analyses of this
disparity revealed that increased ACTH secretion was only
observed in depressed abused children who were experi-
encing ongoing chronic adversity (e.g., marital violence,
emotional abuse, poverty, insufﬁcient social supports).
Taking a developmental psychopathology perspective,
although Kaufman et al. (1997a, b) make no explicit
mention of whether depressed participants were experi-
encing either ﬁrst- or recurrent-onset major depression, we
may assume from the young mean age of participants
(M = 9.5; range 7–13 years) that they had experienced
few previous episodes of depression. To the extent that the
attenuation of ACTH secretion commonly observed in
depressed adults can be accounted for by downregulation
of CRH receptors in response to these individuals’
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people experiencing their ﬁrst depressive episodes likely
have not yet undergone this downregulation. Thus, it might
be expected that the combination of early-onset disease
status (that would impact on normally abundant/sensitive
CRH receptors) and chronic, ongoing adversity (that
would drive overproduction of CRH) would lead to the
augmented ACTH secretion found in these vulnerable
children. This hypothesis of progressive HPA axis dys-
regulation in response to chronic stress exposure parallels
the pattern reported in animal studies (e.g., LeMevel et al.
1979; Vernikos et al. 1982).
Psychological Challenge Studies
While hypothalamic CRH represents the physiological
trigger for activation of the HPA system, psychological
activation of this system begins upstream with affective
information processed in the limbic system. The limbic
system, in turn, stimulates CRH-releasing neurons in the
hypothalamus (e.g., Adam et al. 2008). Since the limbic
system serves as the primary conduit between cognitively
processed exogenous stressors and endogenous physiolog-
ical signals, psychological stressors represent important
probes of the higher-order functioning of the HPA axis.
Surprisingly, there has been little research in this area. As
discussed previously in the introductory sections, although
both depression and the transition to adolescence are
associated with increases in exposure to psychological
stressors, a paucity of studies has addressed HPA axis
response to this class of stimuli among depressed children
and adolescents.
Recall that in normative populations, childhood has been
hypothesized to be a period of hyporesponsivity to psy-
chological stressors, relative to adolescence (Gunnar et al.
2009b;Lupienetal.2009).Forexample,Stroudetal.(2009)
examined the neuroendocrine (salivary cortisol), sympa-
thetic-adrenomedullary (salivary alpha amylase), and car-
diovascular responses of typically developing children and
adolescents to several performance-related tasks (e.g.,
public speaking, mental arithmetic recitation) and to an
ecologically valid peer rejection paradigm (The Yale
Interpersonal Stressor; Stroud et al. 2000). These investi-
gators found that adolescents exhibited signiﬁcantly greater
reactivity across several physiological indices relative to
children for both tasks. The authors argued that while
‘‘heightened reactivity to psychological stressors in typi-
cally developing adolescents may facilitate adaptation to
new challenges of adolescence and adulthood…in high-risk
adolescents, this normative shift may tip the balance toward
stressresponsedysregulationassociatedwithdepressionand
other psychopathology’’ (Stroud et al. 2009, p. 47).
Until very recently, however, no studies had explicitly
compared the HPA axis response patterns to psychological
challenge between pediatric samples of depressed and
‘‘typically developing’’ control participants. Only four such
reports have been published (Hankin et al. 2010; Luby
et al. 2003, 2004; Rao et al. 2008), and two of these pub-
lications utilized data from the same sample (Luby et al.
2003, 2004). Although these few published data reﬂect the
smallest body of literature examining pediatric HPA axis
dysregulation associated with early-onset depression, it is
intriguing to note that the patterns of ﬁndings are by far the
most consistent. All four studies reported signiﬁcant ﬁnd-
ings related to cortisol hypersecretion of depressed
juveniles in response to acute, laboratory-induced psy-
chological stress relative to non-depressed psychiatric
controls or normative volunteers. Given the small number
of published reports, a brief review of each is provided
below.
The two studies by Luby et al. (2003, 2004) examined
HPA reactivity to experimentally induced psychosocial
stress among the same sample of preschool-aged children.
The evidence from these studies suggests continuities of
HPA axis dysfunction in depressive disorders across early
development and into adulthood. Both studies drew upon
data from a relatively large sample of depressed pre-
schoolers together with age-matched psychiatric and nor-
mative comparison groups. The investigators collected
multiple salivary samples before and after stressors that
involved separation from parents and frustrating tasks (e.g.,
not being able to unlock a transparent box with a desirable
toy inside).
The 2003 study revealed that whereas all groups of
children displayed heightened cortisol response to frus-
trating tasks relative to baseline, depressed preschoolers
were the only group to show signiﬁcantly augmented cor-
tisol levels in response to a separation stressor, as well as
an overall pattern of increasing mean cortisol secretion
throughout the 2-h assessment. Importantly, in comparison
with both control groups, depressed children displayed
higher cortisol levels subsequent to their arrival at the
laboratory, perhaps indicating heightened emotional reac-
tivity to the novel experimental paradigm or chronically
elevated basal cortisol levels. Additional subgroup analyses
of these data presented in the 2004 study indicated that
depressed preschoolers experiencing signiﬁcant symptoms
of anhedonia tended to exhibit the greatest cortisol reac-
tivity to acute psychological stress. The authors argued
that, as with adults, anhedonia in children may represent a
marker of a more severe, biologically, and genetically
based depressive subtype. This pattern of more consistent
and pronounced patterns of HPA hyperactivity corre-
sponding to more severe depressive symptomatology par-
allels ﬁndings from studies using DST and CRH probes.
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the Trier Social Stress Test (TSST), a standardized and
validated psychosocial stress protocol that has been shown
to reliably induce HPA activity in adolescents and adults
(Gunnar et al. 2009a; Kirschbaum et al. 1993). The TSST is
an interpersonal stressor that involves the participant being
challenged to perform well on evaluative tasks by an un-
supportive examiner. The TSST was administered to 30
depressed adolescents and 25 healthy volunteers and sys-
tematically measured both baseline and post-TSST samples
of salivary cortisol. Consistent with their hypothesis, the
authors found that although both groups of adolescents
exhibited signiﬁcantly elevated cortisol response to the
TSST relative to their respective baseline levels, depressed
participants showed signiﬁcantly higher and more pro-
longed cortisol secretion following psychosocial stress
induction when compared with control subjects.
Parallel ﬁndings were reported by Hankin et al. (2010).
They used an interpersonal psychosocial stress procedure
to examine cortisol reactivity in a small sample of
depressed children and youths, aged 8–15 years, compared
with a larger, age-matched sample with no evidence of
depression or dysphoria. Prepubertal children with current
MDD had higher initial cortisol levels, but they did not
differ from comparison children in reactivity (20-min post-
stress) or recovery (40-min post-stress) saliva samples.
Conversely, post-pubertal youths with current MDD evi-
denced stronger reactivity to the task than did comparison
youths. Intriguingly, in a parallel analysis of children and
youths with remitted MDD, no differences from the com-
parison groups were noted.
Given the limited literature on response to psychological
stressors in depressed children and adolescents, perspective
is gained from examining studies of cortisol reactivity in
children and adolescents with subclinical levels of
depression (Gunnar et al. 2009b; Hankin et al. 2010;
Klimes-Dougan et al. 2001; Natsuaki et al. 2009). HPA
reactivity to TSST procedures was examined by Klimes-
Dougan et al. (2001; Natsuaki et al. 2009) with a large
sample of 11- to 16-year-old youths with elevated inter-
nalizing and externalizing problems and by Gunnar et al.
(2009b) with unselected participants aged 9–13 years. In
the former study, older adolescent boys showed the stron-
gest reactivity to the task, but it was only for adolescent
girls that having a stronger reaction to the TSST (larger
increase in cortisol from pre-task to 20-min post-task
samples) was associated with having more internalizing
problems (Klimes-Dougan et al. 2001). In subsequent
analyses, youths with early pubertal maturation were found
to have more internalizing problems, and again for girls
only, stronger HPA reactivity to the TSST mediated the
association between early pubertal maturation and inter-
nalizing problems (Natsuaki et al. 2009). Thus, adolescent
girls, and particularly early-maturing girls, appear to show
heightened physiological reactivity to interpersonal stress-
ors that might increase their risk for developing depression-
related problems.
Analogous ﬁndings were reported by Gunnar et al.
(2009b), who noted a developmental increase in cortisol
reactivity to psychosocial stress from childhood to ado-
lescence and found that girls with greater post-TSST cor-
tisol reactivity had more anxious and depressive symptoms.
Together, these ﬁndings of gender differences in the links
between HPA axis response to psychological stressors and
severity of affective problems echo other literature that has
hypothesized that HPA dysregulation might function as one
mechanism underlying sex differences in depression
(Stroud et al. 2000, 2002, 2004, 2009; Zhan-Waxler et al.
2008).
Finally, in addition to studying pediatric depression,
Hankin et al. (2010) examined HPA reactivity to inter-
personal psychosocial stressors in a large sample of chil-
dren in preschool, third grade, sixth grade, and ninth grade
with elevated, but non-clinical, dysphoria. They distin-
guished subclinical dysphoric children from children with
low negative affect, measured temperament and recent
stressful life events and, in the three older groups, assessed
pubertal maturation. The dysphoric preschoolers and third-
graders did not show cortisol increases to the stressors,
whereas the non-dysphoric children had signiﬁcant cortisol
elevations. No group differences were evident for sixth-
graders, but the dysphoric youths in ninth grade showed
stronger cortisol elevations than did the non-dysphoric
youths. Group differences in temperament and life stressors
could not account for these ﬁndings, but pubertal matura-
tion explained the age effects. Regardless of puberty, non-
dysphoric children and youth showed the expected pattern
of moderate HPA reactivity, whereas prepubertal dysphoric
children were relatively hyporesponsive and post-pubertal
dysphoric children were relatively hyper-reactive.
Studies of Children of Depressed Parents
Studies have provided consistent evidence that the off-
spring of depressed parents are themselves at increased risk
for developing depression (Beardslee et al. 1993; Downey
and Coyne 1990; Nomura et al. 2002; Weissman et al.
1986). This possibly reﬂects a genetic component of sus-
ceptibility to depression, alterations to the fetal environ-
ment (such as more cortisol crossing the placental barrier in
depressed mothers), and in the postnatal period, deviations
from appropriate and effective child-rearing by depressed
parents that interfere with children’s healthy emotional
development. All of these mechanisms also could affect
children’s HPA regulation, and researchers have begun to
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mothers. Should the children of depressed parents dem-
onstrate adrenocortical dysregulation prior to evidencing
their own depressive symptoms, this could be taken as
further evidence that atypical HPA axis activity is a pre-
cursor of, and possibly contributing factor to, pediatric
depression.
There have been 13 papers that speciﬁcally examined
the relations between parental depression and cortisol
levels in offspring, with children ranging in age from
neonates through young adults (Ashman et al. 2002;
Brennan et al. 2008; Diego et al. 2004; Dougherty et al.
2009; Essex et al. 2002; Feldman et al. 2009; Field et al.
2004, 2010; Halligan et al. 2004, 2007; Lundy et al. 1999;
Mannie et al. 2007; Young et al. 2006). Most studies
included only depressed mothers, although some included
both depressed mothers and depressed fathers. All of the
papers included non-depressed comparison families and,
strikingly, all of the investigations identiﬁed elevated cor-
tisol levels in one or more measures of HPA axis activity in
the offspring of depressed parents.
For example, in several reports, Field and her colleagues
(2004, 2010; Diego et al. 2004; Lundy et al. 1999) have
found that young infants of mothers with pre- or post-
partum depression have elevated urinary cortisol levels,
relative to infants of anxious mothers or mothers without
psychopathology. Similarly, Brennan et al. (2008) exam-
ined salivary cortisol levels at baseline and in reaction to
psychosocial stressors in 6-month-old infants of mothers
who had depression before they were pregnant, during
pregnancy, or in the postnatal period. They found that,
relative to infants of mothers without depression, there
were elevated basal cortisol levels in the infants of mothers
with perinatal or postnatal depression. Infants of mothers
who had experienced depression only prior to conception
did not differ from infants of non-depressed mothers,
suggesting that genetic transference of risk for depression
alone cannot account for the elevated cortisol levels in
offspring. Although Brennan et al. (2008) did not ﬁnd
differences for HPA reactivity, Feldman et al. (2009) did.
They reported that 9-month-old infants of depressed
mothers had greater elevations in cortisol in response to a
fear-induction paradigm than did infants of mothers with-
out psychopathology.
Several of the studies of children and youths included
measurements of family functioning, stressful life events,
temperament or personality, and similar factors to deter-
mine whether these accounted for differences in cortisol
levels between depressed and non-depressed groups. For
example, Halligan et al. (2004) examined morning and
evening cortisol levels in 13-year-old children of mothers
with postnatal depression. These children had higher and
more variable morning cortisol levels over 10 days,
compared with children of mothers without depression.
This could not be accounted for by mothers’ concurrent
depression, marital conﬂict, life events, and numerous
other factors. When these youths were seen again 3 years
later, Halligan et al. (2007) found that elevated and vari-
able morning cortisol levels at 13 years predicted more
symptoms of depression in the youths at 16 years. Their
earlier cortisol levels also mediated the association
between maternal postnatal depression and youths’
depression, suggesting that adverse effects of maternal
depression in infancy on the development of HPA regula-
tion might be a mechanism for the intergenerational
transmission of depression.
It is not clear that disruptions to the diurnal rhythm of
basal HPA activity in the children of depressed parents are
speciﬁc to the morning period, however. As did Halligan
et al. (2004), Dougherty et al. (2009) found that preschool-
aged children of mothers with melancholic depression had
elevated morning, but not evening, cortisol levels. Mannie
et al. (2007) similarly found that young adults with
depressed parents had higher waking cortisol levels than
young adults without depressed parents; cortisol levels
were not related to the offsprings’ own mental states. Essex
et al. (2002), however, found that preschoolers with
mothers who had both postnatal and concurrent depression
had higher afternoon basal cortisol levels than children of
mothers without depression or only with concurrent
depression. Young et al. (2006) also found that children of
depressed parents had higher cortisol levels at bedtime, but
not earlier in the day, compared with children of parents
without depression. The children of depressed parents also
were less responsive to the DST, evidencing higher waking
and afternoon cortisol levels the day after receiving
dexamethasone.
Conversely, maternal depression during infancy was
unrelated to morning, evening, or reactive cortisol levels in
7- to 8-year-old children in a study by Ashman et al.
(2002). This was despite the authors’ ﬁnding that at an
earlier assessment, when children were 3 years old, there
was an association between maternal depression and chil-
dren’s basal cortisol levels (Hessl et al. 1996, as reported in
Ashman et al. 2002). At the school-age assessment, though,
the children of depressed mothers had higher pre-stress
baseline cortisol levels, and both their baseline and reactive
cortisol levels were associated with the children’s inter-
nalizing problems.
Considered together, these studies present singularly
consistent evidence that parental depression, and particu-
larly maternal depression in the prenatal and postnatal
periods, is associated with atypical HPA axis functioning in
offspring. This is evidenced across developmental periods
and principally in disruptions to basal cortisol levels. Other
factors associated with parental depression, such as
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effects, and the offsprings’ elevated cortisol levels are
apparent prior to there being evidence that they are expe-
riencing depression. Yet in the two samples that were
followed longitudinally (Ashman et al. 2002; Halligan
et al. 2007), HPA dysregulation appeared to set the stage
for the emergence of mental health problems in the off-
spring of depressed parents.
Synthesis and Conclusions
Important, if preliminary, observations can be offered from
this review of the emerging body of literature examining
various components of HPA axis functioning among
depressed children and adolescents. The principal conclu-
sion, drawing from a number of experimental approaches
and ﬁndings, is that there is good evidence that HPA
dysfunction plays a role in depressive syndromes in pop-
ulations of young people. First, this conclusion derives
from the broad similarity of ﬁndings from studies in young
populations with the results observed in research with
adults. Studies of the dexamethasone suppression test
(DST) in pediatric depressed samples have revealed robust
rates of cortisol non-suppression that are comparable to
those found in studies of depressed adults. These data
suggest that at least some forms of child and adolescent
depression are characterized by abnormal stress system
functioning (i.e., cortisol hypersecretion) through inade-
quate responsiveness of the HPA axis to physiological
negative feedback. Moreover, the pediatric DST data
appear to mirror adult ﬁndings of greater HPA axis dys-
regulation associated with inpatient when compared with
outpatient status. It is likely that inpatient status serves as a
proxy for more serious depressive symptomatology,
heightened stress exposure, or a combination of both fac-
tors. Second, early evidence for a similar symptom and/or
stress dose–response pattern has been found in investiga-
tions examining cortisol response to corticotropin-releasing
hormone (CRH) challenge among depressed young people.
Careful research is needed to disentangle these associations
by systematically controlling for the severity of depression
and/or the environmental context of stress.
Third, results from research assessing basal HPA axis
functioning and diurnal variation among child and ado-
lescent samples show some continuity with corresponding
work in adults. On the whole, the evidence supports a
developmental pattern in which basal HPA axis dysfunc-
tion becomes increasingly associated with pediatric
depression with advancing age. Further, emerging longi-
tudinal research provides strong evidence that overall
dysregulated basal HPA activity precedes and predicts the
development of depression in adolescence and early
adulthood. Consistent with the conclusion made by Lopez-
Duran et al. (2009), this does not appear to be due to
dysregulation at any speciﬁc part of the diurnal rhythm.
Rather, depressed children and youth manifest slightly
elevated circulating cortisol levels across the diurnal cycle.
Nonetheless, future work with depressed young people will
gain power from the collection of larger samples sizes,
which may allow for the detection of more subtle changes
across various indices of basal and/or diurnal variation
during this developmental period.
Fourth, initial evidence supports the observation that
depressed children and adolescents demonstrate increasing
cortisol hyper-reactivity with age in response to develop-
mentally appropriate psychological stressors. Indeed, rela-
tive to non-depressed controls, all of the germane studies
reported signiﬁcantly elevated cortisol levels subsequent to
acute psychosocial stress induction in depressed children
and adolescents. These results may also point to the pri-
mary importance of abnormalities in the functions of brain
regions involved in processing or evaluating stressful
events and affective information (i.e., prefrontal cortex,
limbic system). Such abnormalities suggest a neuropatho-
logical mechanism of initial stress system dysregulation
among at least some depressed young people. This still
untapped area represents an important direction for future
multidisciplinary research with depressed children and
adolescents.
Fifth, studies that have examined HPA axis functioning
in asymptomatic children and adolescents of depressed
parents provide consistent evidence that parental depres-
sion, and particularly maternal depression, is associated
with elevated HPA axis functioning in offspring. This
ﬁnding has been observed across developmental periods
and appears to be principally manifested by disruptions to
basal cortisol functioning, which might precede the onset
of symptoms of depression. Interestingly, this HPA dys-
regulation in offspring tends to be associated with maternal
depression occurring during the prenatal and postnatal
periods rather than with a history of maternal depression
prior to conception. This pattern of results, together with
the scarce longitudinal data available, suggests that genetic
risk for depression alone cannot account for the elevated
cortisol levels in offspring and provides further evidence
that HPA axis dysregulation precedes and predicts the
development of depression in young people.
The second principal conclusion that can be drawn from
investigations of HPA axis functioning in pediatric
depression is the centrality of a developmental perspective.
Children and adolescents are not just small adults. The
ﬁndings of the reviewed studies of the functions of young
subjects’ HPA axis diverge in important ways and/or
degrees from those conducted with depressed adults. For
instance, relative to their adult counterparts, depressed
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cortisol non-suppression following the DST. Additionally,
in contrast to the adult data, there were generally smaller
differences between depressed children and adolescents
and control participants on such HPA indices as overall
basal cortisol secretion and natural diurnal variation, as
well as cortisol and ACTH secretion following the
administration of the CRH challenge. This normative cor-
tisol response to CRH infusion among depressed young
people suggests intact hypothalamic and/or adrenal sensi-
tivity to CRH. This could suggest that any HPA axis dys-
regulation among depressed young people may be due to
‘‘upstream’’ factors that affect production of CRH by the
hypothalamus. Above all, there is a pressing need for
research aimed at identifying these and other possible
mechanisms of HPA axis dysfunction among depressed
young people.
Two broad conclusions emerge from developmentally
oriented research examining HPA axis irregularities asso-
ciated with child and adolescent depression. First, the dif-
ferencesinHPAaxisfunctioningthatexistamongdepressed
young people relative to non-depressed individuals appear
to be smaller in scale than those found between their adult
counterparts, but these disruptions to normative HPA axis
functioning might emerge prior to evidence of symptoms of
depression. Second, differences in HPA axis functioning are
found most consistently and prominently in the context of
increased exposure to psychological stress, whether that is a
brief, acute stress (e.g., laboratory-based stress induction) or
a chronic and pervasive stress (e.g., being raised in the
context of maternal depression).
The ostensible discontinuities between the data on the
HPA axis in pediatric populations and those more consistent
and pronounced ﬁndings from adult depression literature
may reﬂect important developmentally associated patterns.
Ratherthanasimpledichotomoustransitionfromabsenceto
presence of HPA axis dysregulation when one compares
child versus adult manifestations of depression, the con-
siderationoflongitudinaldata across developmental periods
suggests more subtle, progressive changes in HPA axis
functioning. Indeed, research conducted with depressed
adultshasfoundapositivecorrelationbetweenageandbasal
cortisol hypersecretion (Asnis et al. 1981; Halbreich et al.
1984). Other cross-sectional studies—which have included
samplesofparticipantsrangingfrominfancytoadulthood—
have also supported the possibility of a developmental
increase in cortisol levels over the pubertal and especially
post-pubertal periods in adolescence (Kenny et al. 1966;
Kiess et al. 1995). Although longitudinal evidence is
exceedingly scarce, Shirtcliff et al. (2005) found that yearly
increases in cortisol in a sample of 6- to 13-year-olds
predicted increases in internalizing symptoms over this
time period.
There is a pressing need for more prospective, longitu-
dinal research to determine whether developmental chan-
ges in HPA functioning could account in part for the
dramatic increases in the rates of depression from child-
hood to adolescence. As well, by more ﬁrmly establishing
the temporal aspects of HPA axis/stress system dysfunc-
tion, it may be determined whether this vulnerability can be
better characterized at various times throughout develop-
ment as a correlate, cause, or consequence of depression. In
other words, it needs to be more clearly explicated whether,
when, and how the HPA axis dysregulation associated with
depression may serve as (1) a ‘‘trait marker’’ (i.e., a pre-
existing biological vulnerability to the development of
depression that remains present regardless of disease sta-
tus); (2) a ‘‘state marker’’ (i.e., a transient, disease-speciﬁc
biological change that occurs concurrently or as a conse-
quence of depression); or (3) a ‘‘scar marker’’ (i.e., a
potentially longstanding pathophysiological consequence
of the disorder, not evident before ﬁrst onset of a depres-
sive episode; Dahl and Ryan 1996).
Regrettably, a salient omission from the extant pediatric
literature is information related to stage of illness (i.e.,
number of depressive episodes, total duration of illness). It
is possible that the observed differences from adult studies
may be primarily attributable to systematically differences
in the proportion of depressed patients experiencing
recurrent as opposed to ﬁrst-onset episodes of the disorder.
Accordingly, it will be critical for future work to consider
the relative contribution of developmental changes in
neurobiology (e.g., altered neurotransmitter activity and
connectivity, onset of pubertal hormones), as well as the
recurrence of disorder in accounting for the progressive
HPA axis dysregulation associated with depression across
the lifespan.
Finally, given the robust and troubling gender differ-
ences in the rates of depression that also emerge in the
context of the transition from childhood to adolescence, it
will be essential to further examine gender differences in
stress system functioning. It is reasonable to hypothesize
that patterns of hyper-reactive HPA axis functioning are
more pronounced and/or have qualitatively different psy-
chosocial triggers for adolescent girls than those for boys
(e.g., Stroud et al. 2009). This notion is supported by the
emerging empirical work indicating that adolescent girls,
and particularly early-maturing girls, without a history of
depression exhibit heightened HPA axis reactivity to
interpersonal stressors. Although this research requires
replication, these ﬁndings closely parallel earlier work
using subjective measures of stress response. For example,
it has been suggested that the greater prevalence of
depression in adolescent girls when compared with boys
may be at least partially explained by girls’ more frequent
exposure and heightened self-reported reactivity to
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123interpersonally themed stressors (e.g., Hankin et al. 2007;
Rudolph 2002). Similarly, there is a critical need for
additional investigations that utilize a developmental psy-
chopathology perspective to determine whether and how
aberrant physiological stress system reactions may interact
with other, possibly gender-speciﬁc sources of physiolog-
ical, psychological, cognitive, and social vulnerabilities.
Multidisciplinary, methodologically rigorous (particu-
larly with respect to subject selection, power, and the
nature and timing of biological sampling) and longitudinal
research designs are needed to further elucidate the role of
the HPA axis in depression, as well as likely transactions
between biological and psychological stress system func-
tioning across development. For example, future prospec-
tive research might beneﬁt from the examination of
possible HPA axis changes associated with certain cogni-
tive vulnerabilities to depression (e.g., a depressogenic
attributional style for negative life events) in high-risk
individuals. Another future avenue of investigation might
utilize an epidemiological approach incorporating psy-
chological, neurological, and endocrinological measures in
depressed, high-risk, and control samples.
There are four salient conclusions from the present
review. First, the extant research clearly supports the pres-
ence of HPA dysregulation in pediatric depression, and it
appears this association strengthens with age. Second, based
on studies examining the DST among depressed samples of
children and adolescents, pediatric depression may involve
particular disruption to higher regulatory (inhibitory) auto-
feedback. Third, available data suggest that HPA dysregu-
lation may precede and predict the onset of depression in
individuals, regardless of age. Fourth and ﬁnally, HPA
dysregulation is evident in acute stress responses and might
result from exposure to chronic early stressors or perturba-
tionstonormalinfantcareexperiences.Althoughadoptinga
developmental psychopathology perspective has helped to
shed light on the ontogenesis of the relation between HPA
axis function and depression, continued child clinical
research is needed to further this understanding with the aim
of informing diagnosis, prognostication, and intervention.
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